Hydrazinocarbonyloxylabdanes for treating cardiac failure

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5142328, 514337, 514365, 514374, 514422, 514432, 514444, 514455, 544 587, 544150, 546196, 546269, 548194, 548215, 548525, 549 28, 549 60, 549358, 549389, A61K 3154, C07D40512

Patent

active

048837938

ABSTRACT:
Novel hydrazinocarbonyloxylabdanes, intermediates and processes for the preparation thereof, and a method for treating cardiac failure utilizing compounds or compositions thereof are disclosed.

REFERENCES:
patent: 3631039 (1971-12-01), Nutley et al.
patent: 4088659 (1978-05-01), Bhat et al.
patent: 4118508 (1978-10-01), Bhat et al.
patent: 4134986 (1979-01-01), Bajwa et al.
patent: 4476140 (1984-10-01), Sears et al.
patent: 4517200 (1985-05-01), Kreutner et al.
patent: 4564626 (1986-01-01), Krevtner et al.
patent: 4639443 (1987-01-01), Kosley et al.
patent: 4639446 (1987-01-01), Kosley et al.
patent: 4666904 (1987-05-01), Kosley et al.
patent: 4672115 (1987-06-01), Kosley et al.
patent: 4673752 (1987-06-01), Kosley et al.
patent: 4677103 (1987-06-01), Kosley et al.
I. Sutherland(Editor), Comprehensive Organic Chemistry, vol. 2, Pergamon Press, New York, 1979, pp. 34-38 and 1049-1051.
De Souza, N., et al., Medicinal Research Reviews, 3, 201(1983).
Bhat, S., et al., J. Med. Chem., 26, 486(1983).
Seamon, K., et al., J. Med. Chem., 26, 436(1983).
Bhat, S., et al., Tett. Lett., No. 19, 1669(1977).
Bhat, S., et al., J.C.S. Perkin I, 767(1982).
Caprioli, J., et al., Invest. Ophth. Vis. Sci., 25, 268(1984).
Caprioli, J., et al., The Lancet, 958(1983).
Seamon, K., et al., Proc. Natl. Acad. Sci. USA, 78(6), 3363(1981).
Seamon, K., et al., J. Biol. Chem., 256(19), 9799(1981).
Takeda, J., et al., J. Invest. Dermatol., 81, 235(1983).
Takeda, J., et al., J. Invest. Dermatol., 81, 131(1983).
Iizuka, H., et al., Biochem. Biophys. Acta, 444, 685(1976).
Iizuka, M., et al., Biochem. Biophys. Acta, 437, 150(1976).
Voorhees, J., et al., J. Invest. Dermatol., 59, 114(1972).
Halprin, K., et al., J. Invest. Dermatol., 65, 170(1975).
Raab, W., Int. J. Clin. Pharmacol. Ther. Toxicol., 18, 212(1980).
Cherill, R., et al., Abstracts of Papers, 192nd ACS Meeting, Medi, No. 48(9/1986).
Caprioli, J., et al., Yale J. Biol. Med., 57, 283(1984).
Seamon, K., et al., Trends Pharmacol. Sci., 48, 120(1983).
Seamon, K., et al., J. Cyc. Nucleotide Res., 7, 201(1981).
Caprioli, J., et al., Abstracts Assn. Res. Vis. Ophthalmol., p. 233, No. 5:15(1986).
Bartels, S., et al., Current Eye Res., 6(2), 307(1987).
Seamon, K., et al., in Advances in Cyclic Nucleotide and Protein Phosphorylation Reasearch, vol. 20, Greengard, P., et al. (editors), Raven Press, NY, 1986, pp. 1-150.
Bartels, S., et al., Current Eye Res., 2, 673(1982/1983).
Laurenza, A., et al., Molec. Pharmacol., 32, 133(1987).
Calbiochem.RTM. Biochemical/Immunochemical Catalog, 1988, Non Product Supp., p. 18, 1987 catalog, p. 102.
Biologics, 13(4), 10/1987.
March, J., Advanced Organic Chemistry, McGraw Hill, New York, 1968, pp. 320-322, 338 and 339.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Hydrazinocarbonyloxylabdanes for treating cardiac failure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hydrazinocarbonyloxylabdanes for treating cardiac failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrazinocarbonyloxylabdanes for treating cardiac failure will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-581903

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.